Recombinant human parathyroid hormone related protein 1-34 and 1-84 and their roles in osteoporosis treatment

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wang, Hua ^a   Liu, Jingning ^a   Yin, Ying ^a   Wu, Jun ^a   Wang, Zilu ^a   Miao, Dengshun ^a   Sun, Wen ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE RELATED PROTEIN; RECOMBINANT HUMAN PARATHYROID HORMONE RELATED PROTEIN 1-34; RECOMBINANT HUMAN PARATHYROID HORMONE RELATED PROTEIN 1-84; UNCLASSIFIED DRUG; CARRIER PROTEIN; PARATHYROID HORMONE-RELATED PROTEIN (1-34); PARATHYROID HORMONE-RELATED PROTEIN (1-84); PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE MINERALIZATION; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM TRANSPORT; CELL DIFFERENTIATION; COLONY FORMATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; RAT; UPREGULATION; ANIMAL; BLOOD; BONE MARROW CELL; C57BL MOUSE; CELL LINEAGE; COMPLICATION; CYTOLOGY; DRUG EFFECTS; HALF LIFE TIME; HUMAN; ISOLATION AND PURIFICATION; KIDNEY; METABOLISM; ORGAN SIZE; OSTEOCLAST; PATHOLOGY; STEM CELL; WISTAR RAT;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CALCIUM; CELL LINEAGE; FEMALE; HALF-LIFE; HUMANS; KIDNEY; MALE; MEMBRANE TRANSPORT PROTEINS; MICE, INBRED C57BL; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; RATS, WISTAR; RECOMBINANT PROTEINS; STEM CELLS;

EID: 84895519024     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088237     Document Type: Article

References (46)

1. Sobieszczanska M, Jonkisz J, Tabin M, Laszki-Szczachor K (2013) Osteoporosis: genetic determinants and relationship with cardiovascular disease. Adv Clin Exp Med 22: 119-124.
2. Girotra M, Rubin MR, Bilezikian JP (2006) The use of parathyroid hormone in the treatment of osteoporosis. Rev Endocr Metab Disord 7: 113-121. (Pubitemid 46049523)
3. Juppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, et al. (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254: 1024-1026. (Pubitemid 21917436)
4. Baron R, Hesse E (2012) Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab 97: 311-325.
5. Borba VZ, Manas NC (2010) The use of PTH in the treatment of osteoporosis. Arq Bras Endocrinol Metabol 54: 213-219.
6. Girotra M, Rubin MR, Bilezikian JP (2006) Anabolic skeletal therapy for osteoporosis. Arq Bras Endocrinol Metabol 50: 745-754. (Pubitemid 44786010)
7. Khan AW, Khan A (2006) Anabolic agents: a new chapter in the management of osteoporosis. J Obstet Gynaecol Can 28: 136-141.
8. Augustine M, Horwitz MJ (2013) Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs as Therapies for Osteoporosis. Curr Osteoporos Rep.
9. Strewler GJ, Nissenson RA (1990) Hypercalcemia in malignancy. West J Med 153: 635-640.
10. Grill V, Rankin W, Martin TJ (1998) Parathyroid hormone-related protein (PTHrP) and hypercalcaemia. Eur J Cancer 34: 222-229. (Pubitemid 28189190)
11. Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, et al. (1996) Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 175: 166-176. (Pubitemid 26148780)
12. Sun W, Liu J, Zhou X, Xiao Y, Karaplis A, et al. (2010) Alterations in phosphorus, calcium and PTHrP contribute to defects in dental and dental alveolar bone formation in calcium-sensing receptor-deficient mice. Development 137: 985-992.
13. Liu J, Lv F, Sun W, Tao C, Ding G, et al. (2011) The abnormal phenotypes of cartilage and bone in calcium-sensing receptor deficient mice are dependent on the actions of calcium, phosphorus, and PTH. PLoS Genet 7: e1002294.
14. Kovacs CS, Lanske B, Hunzelman JL, Guo J, Karaplis AC, et al. (1996) Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci U S A 93: 15233-15238.
15. Clemens TL, Cormier S, Eichinger A, Endlich K, Fiaschi-Taesch N, et al. (2001) Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol 134: 1113-1136. (Pubitemid 33097241)
16. Miao D, Su H, He B, Gao J, Xia Q, et al. (2008) Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein. Proc Natl Acad Sci U S A 105: 20309-20314.
17. Fenton AJ, Martin TJ, Nicholson GC (1993) Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139]. J Cell Physiol 155: 1-7. (Pubitemid 23109050)
18. Abbas SK, Pickard DW, Rodda CP, Heath JA, Hammonds RG, et al. (1989) Stimulation of ovine placental calcium transport by purified natural and recombinant parathyroid hormone-related protein (PTHrP) preparations. Q J Exp Physiol 74: 549-552. (Pubitemid 19192467)
19. Xue Y, Zhang Z, Karaplis AC, Hendy GN, Goltzman D, et al. (2005) Exogenous PTH-related protein and PTH improve mineral and skeletal status in 25-hydroxyvitamin D-1alpha-hydroxylase and PTH double knockout mice. J Bone Miner Res 20: 1766-1777. (Pubitemid 41361877)
20. Conget PA, Minguell JJ (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181: 67-73. (Pubitemid 29400373)
21. Erben RG, Scutt AM, Miao D, Kollenkirchen U, Haberey M (1997) Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow. Endocrinology 138: 4629-4635. (Pubitemid 27460897)
22. Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D (2005) Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum Mol Genet 14: 1515-1528. (Pubitemid 40823460)
23. Miao D, Bai X, Panda D, McKee M, Karaplis A, et al. (2001) Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology 142: 926-939. (Pubitemid 32222443)
24. Panda DK, Miao D, Bolivar I, Li J, Huo R, et al. (2004) Inactivation of the 25- hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279: 16754-16766. (Pubitemid 38509378)
25. Miao D, Scutt A (2002) Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 50: 333-340. (Pubitemid 34171058)
26. Miao D, Scutt A (2002) Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)2D3 response to short-term treatment with 1,25-dihydroxyvitamin D3 in vivo. BMC Musculoskelet Disord 3: 16.
27. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159. (Pubitemid 17064313)
28. Miao D, He B, Karaplis AC, Goltzman D (2002) Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 109: 1173-1182. (Pubitemid 34496595)
29. Wysolmerski JJ (2012) Parathyroid hormone-related protein: an update. J Clin Endocrinol Metab 97: 2947-2956.
30. Bisello A, Horwitz MJ, Stewart AF (2004) Parathyroid hormone-related protein: an essential physiological regulator of adult bone mass. Endocrinology 145: 3551-3553. (Pubitemid 39037533)
31. Abou-Samra AB, Juppner H, Force T, Freeman MW, Kong XF, et al. (1992) Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A 89: 2732-2736.
32. Walsh CA, Birch MA, Fraser WD, Lawton R, Dorgan J, et al. (1995) Expression and secretion of parathyroid hormone-related protein by human bone-derived cells in vitro: effects of glucocorticoids. J Bone Miner Res 10: 17-25.
33. Wealthall RJ (2009) In vitro regulation of proliferation and differentiation within a postnatal growth plate of the cranial base by parathyroid hormone-related peptide (PTHrP). J Cell Physiol 219: 688-697.
34. Miao D, Tong XK, Chan GK, Panda D, McPherson PS, et al. (2001) Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 276: 32204-32213.
35. Datta NS, Abou-Samra AB (2009) PTH and PTHrP signaling in osteoblasts. Cell Signal 21: 1245-1254.
36. Kovacs CS, Kronenberg HM (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18: 832-872. (Pubitemid 28009569)
37. Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, et al. (2005) Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115: 2402-2411. (Pubitemid 41266202)
38. Choi KC, An BS, Yang H, Jeung EB (2011) Regulation and molecular mechanisms of calcium transport genes: do they play a role in calcium transport in the uterine endometrium? J Physiol Pharmacol 62: 499-504.
39. Kumar R, Tebben PJ, Thompson JR (2012) Vitamin D and the kidney. Arch Biochem Biophys 523: 77-86.
40. Walters JR, Balesaria S, Khair U, Sangha S, Banks L, et al. (2007) The effects of Vitamin D metabolites on expression of genes for calcium transporters in human duodenum. J Steroid Biochem Mol Biol 103: 509-512. (Pubitemid 46401275)
41. Cao G, Gu Z, Ren Y, Shu L, Tao C, et al. (2009) Parathyroid hormone contributes to regulating milk calcium content and modulates neonatal bone formation cooperatively with calcium. Endocrinology 150: 561-569.
42. Ji J, Lu R, Zhou X, Xue Y, Shi C, et al. (2011) 1,25-Dihydroxyvitamin D(3) contributes to regulating mammary calcium transport and modulates neonatal skeletal growth and turnover cooperatively with calcium. Am J Physiol Endocrinol Metab 301: E889-900.
43. Godwin SL, Soltoff SP (1997) Extracellular calcium and platelet-derived growth factor promote receptor-mediated chemotaxis in osteoblasts through different signaling pathways. J Biol Chem 272: 11307-11312. (Pubitemid 27184132)
44. Yamaguchi T, Chattopadhyay N, Kifor O, Butters RR Jr, Sugimoto T, et al. (1998) Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res 13: 1530-1538. (Pubitemid 28465293)
45. Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, et al. (2004) Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci U S A 101: 5140-5145. (Pubitemid 38469215)
46. Chang W, Tu C, Chen TH, Bikle D, Shoback D (2008) The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal 1: ra1.